Retiform hemangioendothelioma
Retiform hemangioendothelioma is a rare type of vascular tumor that typically presents as a slow-growing cutaneous nodule or plaque. It was first described in 1994 by Calonje et al. and is characterized by its distinctive "net-like" or "retiform" vascular pattern. Despite its benign clinical course, it is histologically malignant and can be locally aggressive.
Clinical Presentation[edit | edit source]
Patients with retiform hemangioendothelioma typically present with a slow-growing cutaneous nodule or plaque. The lesions are often solitary and are most commonly found on the limbs, although they can occur anywhere on the body. The average age of onset is 33 years, but the condition has been reported in patients ranging from 9 to 76 years of age. There is no significant gender predilection.
Pathology[edit | edit source]
Retiform hemangioendothelioma is characterized by its distinctive "net-like" or "retiform" vascular pattern. The tumor is composed of elongated, thin-walled blood vessels that closely resemble the normal rete arteriole of the skin. The vessels are lined by a single layer of endothelial cells and are often accompanied by a dense inflammatory infiltrate.
Diagnosis[edit | edit source]
The diagnosis of retiform hemangioendothelioma is primarily based on histological examination. Immunohistochemical staining can be helpful in confirming the diagnosis. The tumor cells are typically positive for vascular markers such as CD31, CD34, and Factor VIII.
Treatment and Prognosis[edit | edit source]
The treatment of choice for retiform hemangioendothelioma is complete surgical excision. Despite its histologically malignant appearance, the tumor has a benign clinical course and metastasis is extremely rare. However, local recurrence is common and long-term follow-up is recommended.
See Also[edit | edit source]
References[edit | edit source]
Retiform hemangioendothelioma Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD